LON:LIVN - LivaNova Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeGBX 41.21 - GBX 63VolumeN/AAverage Volume1,913 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression. Receive LIVN News and Ratings via Email Sign-up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry N/A Sub-IndustryN/A SectorN/A SymbolLON:LIVN CUSIPN/A Webwww.livanova.comhome.action Phone+44-20-37865275 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-8.31% Return on Equity-1.00% Return on Assets-1.25% Miscellaneous EmployeesN/A Outstanding Shares48,180,000Market Cap£0.00 LivaNova (LON:LIVN) Frequently Asked Questions What is LivaNova's stock symbol? LivaNova trades on the London Stock Exchange (LON) under the ticker symbol "LIVN." Who are LivaNova's key executives? LivaNova's management team includes the folowing people: Daniel Jeffrey Moore, Chairman of the BoardDamien McDonald, Chief Executive Officer, DirectorThad Allen Huston, Chief Financial OfficerDouglas J. Manko, Chief Accounting OfficerDavid S. Wise, Chief Administrative OfficerFrancesco Bianchi, Independent DirectorStefano Gianotti, Independent DirectorHugh M. Morrison, Independent DirectorAlfred J. Novak, Independent DirectorSharon O'Kane Ph.D., Independent Director How do I buy shares of LivaNova? Shares of LIVN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is LivaNova's official website? The official website for LivaNova is http://www.livanova.com/home.action. How can I contact LivaNova? LivaNova's mailing address is 20 Eastbourne Terrace, LONDON, W2 6LG, United Kingdom. The company can be reached via phone at +44-20-37865275. MarketBeat Community Rating for LivaNova (LON LIVN)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 74 (Vote Outperform)Underperform Votes: 73 (Vote Underperform)Total Votes: 147MarketBeat's community ratings are surveys of what our community members think about LivaNova and other stocks. Vote "Outperform" if you believe LIVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LIVN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/25/2018 by MarketBeat.com StaffFeatured Article: Dividend Stocks - Are They Right For You?